NEW YORK (GenomeWeb) – No longer just a genomic editing tool, CRISPR/Cas9 can also edit the epigenome, according to a study published today in Nature Biotechnology.

By fusing a non-cutting dCas9 protein to a histone-modifying protein, scientists from Duke University, led by Isaac Hilton and Charles Gersbach, created a system that could selectively raise levels of gene expression by increasing activity at a variety of regulatory regions. Moreover, it was able to do so at high specificity with only a single guide RNA.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Sponsored by

This webinar will cover recent advances in the use of CRISPR for generating animal models and cell lines.